These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18402305)

  • 1. Benign hypertrophy of the prostate.
    Mogere RM; Baraza R
    East Afr Med J; 2007 Dec; 84(12):553-5. PubMed ID: 18402305
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of benign prostatic hyperplasia. Alternatives to standard therapy.
    Silverstein JI; Badlani GH; Smith AD
    Clin Geriatr Med; 1990 Feb; 6(1):69-84. PubMed ID: 1689206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography].
    Suzuki K; Ichinose Y; Hashimoto K; Matsumoto K; Suzuki T; Imai K; Yamanaka H
    Hinyokika Kiyo; 1990 May; 36(5):557-60. PubMed ID: 1698012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current therapies of benign prostatic hypertrophy. Can the new medical treatments replace endoscopic resection?].
    Pavone-Macaluso M
    Ann Urol (Paris); 1992; 26(3):140-4. PubMed ID: 1381162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign prostatic hyperplasia.
    Barry M; Roehrborn C
    Clin Evid; 2002 Jun; (7):775-87. PubMed ID: 12230703
    [No Abstract]   [Full Text] [Related]  

  • 6. Benign prostatic hyperplasia.
    Barry M; Roehrborn C; Webber R
    Clin Evid; 2002 Dec; (8):849-63. PubMed ID: 12603916
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical and nonmedical therapies for benign prostatic hypertrophy.
    Loughlin KR
    Geriatrics; 1991 Jun; 46(6):26-31, 34. PubMed ID: 1710196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial comments to Comparison of photoselective vaporization and standard transurethral resection of the prostate on urodynamics in patients with benign prostatic hyperplasia.
    Sugimura Y
    Int J Urol; 2009 Aug; 16(8):662-3. PubMed ID: 19602002
    [No Abstract]   [Full Text] [Related]  

  • 9. Watchful waiting in benign prostatic hyperplasia.
    Wiygul J; Babayan RK
    Curr Opin Urol; 2009 Jan; 19(1):3-6. PubMed ID: 19057209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy for benign prostatic hyperplasia.
    Narayan P; Indudhara R
    West J Med; 1994 Nov; 161(5):495-506. PubMed ID: 7528957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.
    Jeldres C; Isbarn H; Capitanio U; Zini L; Bhojani N; Shariat SF; Cloutier V; Lattouf JB; Duclos A; Jolivet-Tremblay M; Valiquette L; Saad F; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Aug; 182(2):626-32. PubMed ID: 19535100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug therapy of benign prostatic hyperplasia].
    Ekman P
    Lakartidningen; 1992 Nov; 89(45):3803-4. PubMed ID: 1281249
    [No Abstract]   [Full Text] [Related]  

  • 13. New drugs for the prostate.
    Harv Mens Health Watch; 2005 Jun; 9(11):3-8. PubMed ID: 16138402
    [No Abstract]   [Full Text] [Related]  

  • 14. [Using setegis (terasosine) in early postoperative period after transurethral prostate resection].
    Teodorovich OV; Zabrodina NB; Bochkarev AB
    Urologiia; 2009; (3):62-4. PubMed ID: 19673124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailoring treatment in benign prostatic hyperplasia management.
    de la Rosette JJ
    Curr Opin Urol; 2009 Jan; 19(1):1-2. PubMed ID: 19057208
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inguinal hernia repair and resection for benign prostatic hypertrophy--should they be performed as a combined procedure?].
    Guy L
    J Chir (Paris); 2009 Dec; 146(6):523-4. PubMed ID: 19931861
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of an anti-androgen, SH 714 (6-chlor-delta-6-1, 2-alpha-methylen-17-alpha-hydroxyprogesterone acetate, cyproterone acetate) on canine prostatic hyperplasia.
    Neri RO; Casmer C; Zeman WV; Fielder F; Tabachnick II
    Endocrinology; 1968 Feb; 82(2):311-7. PubMed ID: 4170420
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of the surgical treatment of benign hypertrophy of the prostate].
    Fourcade RO; Lanson Y; Teillac P
    Prog Urol; 1993 Oct; 3(5):823-915. PubMed ID: 7510569
    [No Abstract]   [Full Text] [Related]  

  • 19. Benign prostatic hyperplasia.
    Webber R
    Clin Evid; 2005 Dec; (14):1076-91. PubMed ID: 16620448
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Frans Debruyne, Arkadij A. Gres, Dmitrii L. Arustamov. Placebo-controlled dose-ranging phase 2 study of subcutaneously administered LHRH antagonist Cetrorelix in patients with symptomatic benign prostatic hyperplasia. Eur Urol 2008;54:170-80.
    Drewa T; Chlosta P
    Eur Urol; 2009 Feb; 55(2):e36-7; author reply e38-9. PubMed ID: 18703271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.